vaginal atrophy


Also found in: Acronyms.

vaginal atrophy

[vaj′ənəl]
a postmenopausal condition of gradually declining tissue activity in the female reproductive tract. It is caused by a cessation of follicular inhibin and estrogen secretion. This leads to decreased negative feedback on the release of follicle-stimulating hormone and luteinizing hormone by the anterior pituitary gland. Tissue effects related to estrogen deficiency include atrophy and dystrophy of the vulva and vagina, pruritus vulvae, dyspareunia, cystourethritis, ectropion, and uterovaginal prolapse.

vaginal atrophy

A condition characterised by thinning, drying, and often dyspareunia and irritation of the vagina. Vaginal atrophy most commonly occurs in menopausal and postmenopausal women, and less commonly during breast feeding or in association with reduced oestrogen production in premenopausal women.

Management
Oestrogen creams.

vaginal atrophy

Atrophic vaginitis, see there.
References in periodicals archive ?
Ospemifene is a newer oral selective estrogen receptor modulator (SERM) that is approved by the FDA for the treatment of dyspareunia caused by vaginal atrophy in post-menopausal women (Soe et al.
One way to fend off vaginal atrophy is to have sex, another is self-pleasure.
Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial.
Our study sought to determine the effects of using a vaginal estrogen cream in the treatment of vaginal atrophy in menopausal women in India.
The report provides a snapshot of the global therapeutic landscape of Vaginal Atrophy (Atrophic Vaginitis)
Vaginal atrophy and the loss of lubrication and elasticity can make sexual encounters painful, depress libido and cause irritation and bleeding during exercise.
Vaginal atrophy is a condition in which low estrogen levels cause a woman's vagina to narrow, lose flexibility and take longer to lubricate.
Very low dosages of transvaginal oestrogens in the forms of creams, tablets and rings are effective for vaginal atrophy and urinary incontinence.
REDUCED oestrogen levels after menopause lead to a thinning of the vaginal wall, known as vaginal atrophy.